Lyell Immunopharma LYEL
NASDAQ LYEL
$16.86 +0.11 (+0.66%)
At close: Nov 11, 2026 · 4:00 PM EST

Lyell Immunopharma (LYEL) Return on Assets [ROA] (2021 - 2026)

Updated

Lyell Immunopharma (LYEL) reported Return on Assets [ROA] of -77.52% for Q2 2026, up 9.86 percentage points from -87.37% a year earlier but down 3.30 percentage points from the prior quarter.

Analysis

Lyell Immunopharma (LYEL) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Lyell Immunopharma posted Return on Assets [ROA] of -64.85%, down 7.02 percentage points from FY2024.

  • Return on Assets [ROA] has declined for three consecutive years, with a four-year change of -43.74 percentage points (FY2021 to FY2025).
  • By year, Return on Assets [ROA] came in at -57.82% in FY2024 (-28.55 pp), -29.27% in FY2023 (-11.16 pp), -18.12% in FY2022 (+2.98 pp) and -21.10% in FY2021.
  • Five-year quarterly Return on Assets [ROA] spans a low of -87.37% in Q2 2025 and a high of -16.99% in Q3 2021.
  • Year over year, Return on Assets [ROA] gained in two of the last eight quarters, with an average year-over-year change of -23.34 percentage points.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q2 2026 (a gain of 9.86 percentage points); the low point was Q2 2025 (a drop of 53.90 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -74.22% (Q1 2026), -72.03% (Q4 2025) and -86.44% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Lyell Immunopharma 411.74 Mn -470.71 Mn - -87.40%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -87.40%
Jun 30, 2026 -75.16%
Mar 31, 2026 -71.40%
Dec 31, 2025 -73.39%
Sep 30, 2025 -82.23%
Jun 30, 2025 -81.19%
Mar 31, 2025 -72.55%
Dec 31, 2024 -61.73%
Sep 30, 2024 -31.73%
Jun 30, 2024 -30.89%
Mar 31, 2024 -31.14%
Dec 31, 2023 -29.40%
Sep 30, 2023 -22.24%
Jun 30, 2023 -23.72%
Mar 31, 2023 -19.72%
Dec 31, 2022 -19.75%
Sep 30, 2022 -26.85%
Jun 30, 2022 -23.45%
Mar 31, 2022 -24.56%
Dec 31, 2021 -21.68%
API Access

Lyell Immunopharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LYEL&period=max&api_key=YOUR_API_KEY